Apremilast


( Last Updated : January 29, 2016)
Generic Name:
Apremilast
Project Status:
Complete
Therapeutic Area:
Psoriasis, moderate to severe plaque
Manufacturer:
Celgene
Call for patient/clinician input open:
Brand Name:
Otezla
Project Line:
Reimbursement Review
Project Number:
SR0478-000
Call for patient/clinician input closed:

Details


Submission Type:
Resubmission
Indications:
Psoriasis, moderate to severe plaque
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: